Glioblastoma: all 1,951 studies
Page 17 of 20. Open to participants first (457), then studies with results posted, then the rest; newest registration first within each.
- Safety Study of VAL-083 in Patients With Recurrent Malignant GliomaCompletedNCT01478178Phase 1/2
- AMG 595 First-in-Human in Recurrent GliomasCompletedNCT01475006Phase 1
- A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GlioblastomaCompletedNCT01473901Phase 1
- Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain TumorCompletedNCT01470794Phase 1
- AZD7451 for Recurrent GliomasCompletedNCT01468324Phase 1
- Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma MultiformeCompletedNCT01464177Phase 2
- Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma MultiformeCompletedNCT01450449Phase 3
- More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided SurgeryWithdrawnNCT01445691Phase 2
- Avastin Plus Radiotherapy in Elderly Patients With GlioblastomaCompletedNCT01443676Phase 2
- A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.WithdrawnNCT01441388Phase 1
- Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma MultiformeCompletedNCT01435395Phase 1
- Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation TherapyTerminatedNCT01430351Phase 1
- Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple MyelomaCompletedNCT01421524Phase 1
- Bevacizumab With or Without Surgery for Adult GlioblastomasWithdrawnNCT01413438Phase 2
- Peptide-based Glioma Vaccine IMA950 in Patients With GlioblastomaTerminatedNCT01403285Phase 1
- HYPAZ: Hypertension Induced by PazopanibTerminatedNCT01392352Phase 2
- Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant GliomaCompletedNCT01392209Phase 1
- Olaparib and Temozolomide in Treating Patients With Relapsed GlioblastomaCompletedNCT01390571Phase 1
- Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic AstrocytomaSuspendedNCT01386710Phase 1/2
- High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent GliomaTerminatedNCT01378481Phase 1
- Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed GlioblastomaCompletedNCT01364064Phase 3
- Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.CompletedNCT01353625Phase 1
- A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain TumorsTerminatedNCT01351519Phase 2
- Comparison of Different Methods to Test MGMT Status in Glioblastoma PatientsCompletedNCT01345370
- Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade GliomaTerminatedNCT01339039Phase 1
- Optic Neuropathy in 10 Patients With Glioblastoma Receiving BevacizumabWithdrawnNCT01331616Early Phase 1
- Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade GliomasStatus unknownNCT01317888Not applicable
- Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma MultiformeWithdrawnNCT01317212Phase 1
- AZD8055 for Adults With Recurrent GliomasCompletedNCT01316809Phase 1
- A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent GlioblastomaCompletedNCT01308684Phase 1
- Metronomic Temozolamide in Patients With Recurrent GlioblastomaStatus unknownNCT01308632Phase 2/3
- Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.CompletedNCT01301430Phase 1/2
- Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)CompletedNCT01294735Phase 1
- Dendritic Cell Vaccination for Patients with Solid TumorsCompletedNCT01291420Phase 1/2
- Bevacizumab and Lomustine for Recurrent GBMCompletedNCT01290939Phase 3
- Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT01285414Phase 2
- (11C)dLop as a Marker of P-Glycoprotein Function in Patients With GliomasTerminatedNCT01281982
- BG & TMZ Therapy of Glioblastoma MultiformeCompletedNCT01269424Phase 1
- RO4929097 in Treating Patients With Recurrent Invasive GliomasTerminatedNCT01269411Phase 1
- Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma MultiformeCompletedNCT01260506Phase 1/2
- Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma MultiformeStatus unknownNCT01252459Phase 2
- BIBF 1120 in Recurrent Glioblastoma MultiformeCompletedNCT01251484Phase 2
- Vaccine Therapy and Sargramostim in Treating Patients With Malignant GliomaCompletedNCT01250470Phase 1
- Temozolomide in Elderly Patients With KPS < 70CompletedNCT01242566Phase 2
- Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical ResectionCompletedNCT01240460Phase 1
- Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AACompletedNCT01238237Phase 1
- Yoga Therapy in Treating Patients With Malignant Brain TumorsTerminatedNCT01234805Not applicable
- Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain MetastasesCompletedNCT01234740Phase 1
- Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma MultiformeTerminatedNCT01233492Phase 1
- A Trial Of PF-04856884 In Patients With Recurrent GlioblastomaWithdrawnNCT01225510Phase 2
- Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT01222221Phase 1
- Dendritic Cell Cancer Vaccine for High-grade GliomaCompletedNCT01213407Phase 2
- Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)Status unknownNCT01208909
- Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma MultiformeTerminatedNCT01205334Phase 1/2
- Dendritic Cell Vaccine for Patients With Brain TumorsCompletedNCT01204684Phase 2
- SCH-900105 in Recurrent GlioblastomaWithdrawnNCT01189513Phase 1
- Vitamin D for Treatment of Glioblastoma MultiformeStatus unknownNCT01181193Phase 1/2
- Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AACompletedNCT01180816Phase 1
- New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and NeuroblastomaWithdrawnNCT01174537Phase 1/2
- A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade GliomasCompletedNCT01172964Phase 1
- Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain TumorCompletedNCT01171469Phase 1
- Effects of Steroid Tapering on Functional Capacity and NeurocognitionWithdrawnNCT01169415Not applicable
- Carbon Ion Radiotherapy for Primary GlioblastomaCompletedNCT01165671Not applicable
- Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant GliomaCompletedNCT01165632Early Phase 1
- A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant GliomaCompletedNCT01156584Phase 1
- Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain TumorsCompletedNCT01151670Phase 1
- Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT01149850Phase 2
- Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma PatientsCompletedNCT01149109Phase 3
- Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain TumorsTerminatedNCT01148966Phase 1
- Cellular Immunotherapy Study for Brain CancerCompletedNCT01144247Phase 1
- Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme PatientsCompletedNCT01135875
- Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsCompletedNCT01131234Phase 1
- Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or GliosarcomaStatus unknownNCT01124539Phase 2
- BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain TumorCompletedNCT01124461
- Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter GeneStatus unknownNCT01124240Phase 2
- Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma MultiformeTerminatedNCT01122888Phase 1
- RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaCompletedNCT01119599Phase 1
- A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With GliomasWithdrawnNCT01117155
- A Panobinostat PresurgeryWithdrawnNCT01115036Phase 2
- PF-00299804 in Adult Patients With Relapsed/Recurrent GlioblastomaCompletedNCT01112527Phase 2
- Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain TumorsCompletedNCT01111097Phase 1
- CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBMCompletedNCT01109095Phase 1
- Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant GliomasStatus unknownNCT01107522Phase 1
- Evaluating Tumor Pseudoprogression With FLT-PET and MRITerminatedNCT01105988Early Phase 1
- Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant GliomaTerminatedNCT01103375Phase 1
- Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable GlioblastomaCompletedNCT01102595Phase 2
- Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma PatientsCompletedNCT01100177Phase 2
- Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)CompletedNCT01091792Early Phase 1
- Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme PatientsCompletedNCT01089868
- Radiosurgery Plus Bevacizumab in GlioblastomaTerminatedNCT01086345Early Phase 1
- A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.Status unknownNCT01083719Phase 2
- Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2CompletedNCT01082926Phase 1
- Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsCompletedNCT01076530Phase 1
- APG101 in GlioblastomaCompletedNCT01071837Phase 2
- Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated GlioblastomaTerminatedNCT01044225Phase 2
- Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in AdultsCompletedNCT01043536Phase 1
- Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable GlioblastomaCompletedNCT01022918Phase 2
- A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV GliomaCompletedNCT01020292Phase 1
- Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed GlioblastomaCompletedNCT01019434Phase 2
- Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent GliomaTerminatedNCT01011231Phase 2